We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Six Previously Unreported Genes Linked to Risk of Developing Parkinson's Disease

By LabMedica International staff writers
Posted on 13 Aug 2014
Print article
Image: Researchers used gene chips like this one to identify new genes that may be involved with the development of Parkinson\'s disease (Photo courtesy of the [US] National Human Genome Research Institute).
Image: Researchers used gene chips like this one to identify new genes that may be involved with the development of Parkinson\'s disease (Photo courtesy of the [US] National Human Genome Research Institute).
Genomic researchers have identified more than two dozen genetic risk factors implicated in the development of Parkinson's disease including six genetic loci that had not been reported previously.

Investigators at the [US] National Institutes of Health (Bethesda, MD, USA) reviewed and collated data from genome-wide association studies (GWAS) in order to identify common variants in the genomes of 13,708 Parkinson's disease patients and 95,282 controls, all of European ancestry.

They reported the identification of 26 loci as having genome-wide significant association. These and six additional previously reported loci were then tested in an independent set of 5,353 cases and 5,551 controls. Using a sophisticated gene chip called NeuroX, the investigators confirmed that 24 variants represented genetic risk factors for Parkinson's disease, including six variants that had not been previously identified. The NeuroX gene chip incorporates approximately 24,000 common genetic variants thought to be associated with a broad spectrum of neurodegenerative disorders.

"The study brought together a large international group of investigators from both public and private institutions who were interested in sharing data to accelerate the discovery of genetic risk factors for Parkinson's disease," said contributing author Dr. Margaret Sutherland, a program director at the [US] National Institute of Neurological Disorders and Stroke. "The advantage of this collaborative approach is highlighted in the identification of pathways and gene networks that may significantly increase our understanding of Parkinson's disease. The replication phase of the study demonstrates the utility of the NeuroX chip for unlocking the secrets of neurodegenerative disorders. The power of these high tech, data-driven genomic methods allows scientists to find the needle in the haystack that may ultimately lead to new treatments."

The study was published in the July 27, 2014, online edition of the journal Nature Genetics.

Related Links:
.
National Institutes of Health


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.